Brief: Medicure announces FDA approval for Apicore's generic tetrabenazine

Medicure

23/03/2017 11:30

March 23 (Reuters) -  
    * Medicure announces FDA approval for Apicore's generic 
tetrabenazine 
    * Medicure Inc - its unit has received final approval from 
FDA for co's ANDA for tetrabenazine tablets in 12.5 mg and 25 mg 
strengths 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nPn2Z5x1sa 
Further company coverage:  MPH.V  
 
 ((bangalore.newsroom@thomsonreuters.com;))